Related Experiment Video
Updated: May 13, 2026

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Resveratrol, wine, and atherosclerosis.
1Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Summary
Resveratrol shows potential in combating atherosclerosis by acting as an antioxidant and anti-inflammatory agent. However, robust clinical trials are needed to confirm its value in preventing cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Nutraceutical Research
- Pharmacology
Background:
- Atherosclerosis is a complex disease involving inflammation and lipid accumulation.
- Resveratrol, found in wine, is recognized for its antioxidant and anti-inflammatory properties.
- Understanding resveratrol's impact on atherosclerosis mechanisms is crucial for cardiovascular health.
Purpose of the Study:
- To review the effects of resveratrol on atherosclerosis mechanisms and risk factors.
- To discuss the role of wine and resveratrol in atherosclerosis.
- To evaluate the potential of resveratrol in cardiovascular disease prevention.
Main Methods:
- Review of existing literature on resveratrol's effects on cellular and molecular factors in atherosclerosis.
- Analysis of epidemiological data on alcohol consumption and atherosclerosis.
- Examination of animal models investigating resveratrol's anti-atherosclerotic effects.
Main Results:
- Resveratrol reduces key factors in atherosclerosis, including cell adhesion molecules, inflammatory markers, and lipid levels.
- It inhibits platelet aggregation and vascular smooth muscle cell proliferation.
- Animal studies show resveratrol reduces atherosclerosis extent, though human data and clinical trials are limited.
Conclusions:
- Resveratrol exhibits significant potential as an anti-atherosclerotic agent due to its antioxidant and anti-inflammatory actions.
- While animal studies are promising, robust clinical trials are lacking to establish resveratrol's efficacy in preventing coronary and peripheral artery disease.
- Further in-depth research is required to validate resveratrol's therapeutic value in cardiovascular disease prevention.
Related Concept Videos
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...